For centuries, menstruation has been viewed primarily as a hygienic event—something to be managed, hidden, and often dismissed. But what if this monthly cycle could be a powerful tool to uncover critical health insights?
With 1.8 billion people menstruating worldwide, menstrual blood holds untapped potential as a non-invasive diagnostic resource. Yet, it remains largely overlooked in mainstream healthcare. That is changing with Dr. Sara Naseri, MD, the pioneering CEO and co-founder of Qvin, whose groundbreaking work is redefining how women’s health is understood and monitored.
Join us for an exclusive episode of Peli Health’s Pelvic Power Hour, where we will explore how menstrual blood testing is breaking barriers in diagnostics, improving access to essential health screenings, and closing the gender health gap.
Save your front row seat to the on-demand release, delivered straight to your inbox!
What You’ll Learn
This event features Dr. Naseri, whose leadership at Qvin led to the creation of the FDA-cleared Q-Pad, a first-of-its-kind menstrual pad that turns period blood into a diagnostic tool.
With the recent FSA/HSA eligibility announcement for Q-Pad A1c tests, millions of Americans can now access affordable, non-invasive at-home testing for diabetes management, making healthcare more inclusive and accessible.
Dr. Naseri will share her journey of breaking taboos, overcoming research challenges, and pioneering menstrual blood as a powerful health biomarker. The discussion will focus on how the Q-Pad makes it easier than ever for women to track their health from the comfort of their homes while addressing barriers like cost, time, and accessibility.
Revolutionizing Women’s Health: The Role of Menstrual Blood in Diagnostics
Traditional diagnostic testing often requires invasive blood draws and time-consuming lab visits. Qvin’s menstrual blood testing technology offers an alternative that aligns with women’s natural cycles, no needles, no clinic appointments, just simple and effective at-home testing.
With ongoing research conducted in partnership with Stanford University School of Medicine, the Q-Pad has the potential to detect biomarkers for a range of health conditions, including:
- Diabetes (A1c levels) – Helping women track and manage diabetes without traditional blood draws.
- Thyroid health – Early detection of imbalances that impact energy, metabolism, and fertility.
- Fertility and reproductive health – Offering new ways to monitor hormonal changes and optimize conception.
- Perimenopause and menopause – Tracking shifts in hormone levels to support personalized care.
- Endometriosis and pelvic health conditions – Exploring how menstrual blood can offer insights into chronic conditions often misdiagnosed or overlooked.
- Future applications – Qvin is researching menstrual blood’s potential role in HPV screening and reproductive hormone monitoring, expanding its impact on preventive care.
Why You Should Attend
- Unlock the Power of Menstrual Blood – Learn how it can transform the way health is monitored and improve diagnostics for women.
- Close the Gender Health Gap – Discover how accessible tools like the Q-Pad are breaking down healthcare barriers.
- The Future of At-Home Diagnostics – Gain insights into the latest advancements in non-invasive testing for conditions like endometriosis, PCOS, and diabetes.
- Redefining Women’s Healthcare – Understand how innovation, research, and advocacy are driving change in the medical field.
The average woman experiences 450 periods in her lifetime, yet few realize the potential health insights hidden within menstrual blood. This session will challenge conventional views, answer key questions, and provide valuable information about the future of women’s health.
Meet Dr. Sara Naseri, MD
Dr. Sara Naseri is a physician, scientist, and entrepreneur redefining the way women’s health diagnostics are approached. As the co-founder and CEO of Qvin, she led the creation of the first FDA-cleared menstrual blood testing device, the Q-Pad.
Her pioneering work has been recognized in peer-reviewed research, including her landmark study in the Journal of Clinical and Laboratory Medicine (2019), which demonstrated the clinical relevance of menstrual blood as a health resource rather than waste.
Dr. Naseri and her team at Qvin are dedicated to making healthcare more accessible, affordable, and inclusive, especially for underserved populations who face systemic barriers to routine testing.
About Peli Health
Peli Health is transforming pelvic health for women at every stage of life. Through evidence-based tools, expert resources, and holistic support, Peli Health helps women manage conditions like incontinence, pelvic pain, perimenopause, and postpartum recovery. The mission is to make pelvic care a priority, ensuring women have the knowledge and tools they need to live with less pain, fewer leaks, and greater confidence.
Learn more about pelihealth.com
Get Expert Answers, No More Guesswork
Tired of sifting through confusing, unreliable health info? Peli Health gives you direct access to expert-led discussions, real answers, and a supportive community—all in one place.
Join now for expert Q&As, bite-sized insights, and trusted guidance on everything from periods to pelvic health. No fluff, no myths—just the facts you need to take charge of your health.
Sign up today and get the knowledge you deserve!
Final Thoughts
This event is not just about innovation, it is about redefining the way women access and understand their health. Menstrual blood is more than waste. It is data. It is power. And it is time to start using it.
Join us in reshaping the future of women’s healthcare, one period at a time.
